ALDH1A1-IN-2

CAS No. 2231081-18-6

ALDH1A1-IN-2( —— )

Catalog No. M35715 CAS No. 2231081-18-6

ALDH1A1-IN-2 is a potent aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitor with anticancer activity and may be used in research on breast cancer, inflammation, or obesity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 302 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ALDH1A1-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    ALDH1A1-IN-2 is a potent aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitor with anticancer activity and may be used in research on breast cancer, inflammation, or obesity.
  • Description
    ALDH1A1-IN-2 is a potent inhibitor of aldehyde dehydrogenase 1a1 (aldh1a1). Aldehyde dehydrogenases (ALDH) constitute a family of enzymes that play a critical role in oxidizing various cytotoxic xenogenic and biogenic aldehydes. ALDH1A1-IN-2 has the potential for the research of cancer, inflammation, or obesity (extracted from patent WO2019089626A1, compound 295).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    Dehydrogenase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2231081-18-6
  • Formula Weight
    494.99
  • Molecular Formula
    C25H23ClN4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 1 mg/mL (2.02 mM; Ultrasonic (<60°C)
  • SMILES
    CS(=O)(=O)N1CCN(CC1)C(=O)c1cnc2ccc(Cl)cc2c1-c1ccc(cc1)C1(CC1)C#N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shyh Ming YANG, et al. Substituted quinoline analogs as aldehyde dehydrogenase 1a1 (aldh1a1) inhibitors. Patent WO2019089626A1.
molnova catalog
related products
  • DHODH-IN-8

    DHODH-IN-8 has antimalarial activity. DHODH-IN-8 is an inhibitor of human and Plasmodium falciparum dihydroorotate dehydrogenase (DHODH) .

  • IDH1-IN-1

    Mutant IDH1-IN-1 is a potent mutant IDH1 R132H inhibitor with IC50 < 0.1 uM(A level in Patent).

  • IDH889

    IDH889 is a brain penetrant, an allosteric and mutant specific IDH1 inhibitor. IDH889 has effective selectivity for IDH1 R132* mutations (IC50s: 0.02 μM, 0.072 μM, and 1.38 μM for IDH1R132H, IDH1R132C, and IDH1wt).